Education
About Us
Working with TipRanks
Follow Us
Astrana Health Inc. (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $34.80
Previous CloseN/A
Volume92.25K
Average Volume (3M)510.20K
Market Cap
$1.02B
Enterprise Value$1.64B
Total Cash (Recent Filing)$463.45M
Total Debt (Recent Filing)$1.09B
Price to Earnings (P/E)107.0
Beta1.12
Next Earnings
Mar 02, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding50,155,613
10 Day Avg. Volume355,889
30 Day Avg. Volume510,203
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)2.11
Price to Sales (P/S)0.74
P/FCF Ratio34.04
Enterprise Value/Market Cap1.61
Enterprise Value/Revenue0.57
Enterprise Value/Gross Profit5.60
Enterprise Value/Ebitda15.21
Forecast
1Y Price Target
$34.00Price Target Upside82.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)1.35
Revenue Forecast (FY)$3.96B
Bulls Say, Bears Say
Bulls Say
Growth And Margin OutlookShift to risk-based reimbursement combined with organic expansion in core and emerging markets supports expectations for sustained double-digit revenue growth and EBITDA margin improvement as the macro environment improves.
Risk-contract StrategyCompany's expansion into full-risk contracts and reliance on direct patient encounters reduces exposure to diagnosis-sourcing rule changes and aligns revenue with outcomes-based care.
Valuation OpportunityAnalyst views the sharp share decline as an overreaction and says the stock could reach parity with peers given the company's superior financial profile and potential catalysts.
Bears Say
Medicare Policy HeadwindGovernment proposal for Medicare Advantage rate settings disappointed investors and has pressured the stock by lowering revenue expectations tied to those rates.
Regulatory Diagnosis SourcingProposed rules that would disallow diagnoses from audio-only encounters and certain chart review methods threaten revenue streams that depended on those diagnosis sources.
Revenue Concentration RiskHigh dependence on Medicare-plan revenue increases vulnerability to policy changes and contributed to a sharper share-price decline relative to peers.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $34.80 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.02B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Mar 02, 2026 which is tomorrow.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Nov 06, 2025. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.466 by -$0.456.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.11.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 50,155,613 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.01 in its last earnings report, missing expectations of $0.466. Following the earnings report the stock price went down -23.441%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$34.00 (82.89% Upside)
$34.00 (82.89% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 184.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 11.7%
Last 30 Days ▼ 11.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.59%
12-Months-Change
Fundamentals
Return on Equity
1.29%
Trailing 12-Months
Asset Growth
74.05%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call highlighted significant revenue and EBITDA growth, successful integration of Prospect Health, and technological advancements. However, delays in full risk contract transitions and potential Medicaid headwinds presented challenges. The positive aspects, including strong financial performance and strategic partnerships, were more prominent.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$34.00
▲(82.89% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.34% Insiders
17.66% Mutual Funds
6.65% Other Institutional Investors
7.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---